CNIO - Spanish National Cancer Research Centre
Jose Garrido Mesa is a Senior Research Associate at both Instituto de Investigación Hospital 12 de Octubre and the Spanish National Cancer Research Centre (CNIO) since August 2023. Previously, Jose held the role of Clinical Research Associate at King's College London from February 2020 to November 2023, where responsibilities included coordinating clinical trials, managing research projects, and handling ethics and regulatory aspects. Prior experience includes serving as a Postdoctoral Research Associate at Queen Mary University of London, leading pre-clinical drug development collaborations, and completing a PhD at Universidad de Granada, where multifaceted projects in pharmacology were coordinated. Jose has completed advanced studies in Biochemistry, Biotechnology, Pharmaceutical Sciences, and Pharmacy across esteemed institutions, and has participated in various research fellowships internationally.
This person is not in the org chart
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.